Pneumococcal Vaccine
23-Valent polysaccharide pneumococcal vaccine not effective in Navajo adults
Published in Medical Letter on the CDC and FDA, September 7th, 2003
According to a study from the United States, "Invasive pneumococcal disease occurs two- to three-fold more often among Navajo adults than among adults in the general United States population. The objective of this observational study was to determine the effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) among Navajo adults."
"Active surveillance identified cases of invasive pneumococcal disease during 1996-1997," reported Andrea L. Benin and collaborators at the Centers for Disease Control and Prevention. "Three...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- HIV/AIDS Epidemiology
Prevalence of HIV infection increasing in older Americans - Malaria
Exoerythrocytic stages of Plasmodium inui shortti shown in new world monkeys - HIV/AIDS Diagnosis
Finger-stick HIV test is accurate and acceptable to women in Thailand - Herpesvirus
Herpesvirus 8 infection linked to hepatitis B and HIV infections in Ugandans - Pharmacokinetics
FDA incentive program improves study of medications for children - Allergy Medicine
Protein digestibility related to allergenicity - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
